Serum procalcitonin in pneumococcal pneumonia in children

Citation
M. Korppi et S. Remes, Serum procalcitonin in pneumococcal pneumonia in children, EUR RESP J, 17(4), 2001, pp. 623-627
Citations number
21
Categorie Soggetti
Cardiovascular & Respiratory Systems","da verificare
Journal title
EUROPEAN RESPIRATORY JOURNAL
ISSN journal
09031936 → ACNP
Volume
17
Issue
4
Year of publication
2001
Pages
623 - 627
Database
ISI
SICI code
0903-1936(200104)17:4<623:SPIPPI>2.0.ZU;2-E
Abstract
Serum procalcitonin (PCT), a marker of bacterial infection, was measured in children with pneumonia to examine whether PCT can be used to screen pneum ococcal (PNC) from viral pneumonia. The number of patients was 132; mean age 3.0 yrs, and 64% were males, In al l cases, pneumonia was radiologically confirmed, being alveolar in 46 and i nterstitial in 86 cases, The aetiology of infection was studied by a panel of serological tests for PNC, for five other respiratory bacteria and for s even common respiratory viruses. PNC infection was found in 25, mixed viral -PNC infections in 13 and viral infection in 17 cases. In general, serum PCT was not associated with the type or aetiology of pneu monia. PCT values were >1.0 mg.L-1 in 40% of PNC cases, as compared to 12-1 5% in viral or mixed casts, respectively (p<0.05). PCT values were signific antly higher in >2 yrs old children than in younger ones, The cut-off limit s of 0.5 ng.mL 10 ng . mL(-1) and 2.0 ng . mL(-1) were tested for screening between PNC and viral pneumonia, The highest sensitivity of 55% was found at the 0.5 ng . mL(-1) cut-off level, whereas the highest specificity of 88 % was reached at the level of 1.0 ng mL(-1). The likelihood ratios, however , were far from optimal for both the positive and negative results. Although marginally higher in pneumococcal pneumonia than in viral pneumoni a, serum procalcitonin cannot be used to discriminate between these two typ es of pneumonia.